Nikki Glaser is a big fan of Ozempic. The comedian, 40, appeared on “The Tonight Show Starring Jimmy Fallon” Monday and ...

Novo Nordisk will pay $200 million up front, with up to $1.8 billion in additional payments down the line, The Wall Street ...

Glucagon-like peptide-1 agonists, a class of medications known as GLP-1s, have grown in popularity, initially for the ...

Unlike the US, Europe or other developed markets, Mounjaro will have to be purchased out-of-pocket in India, as obesity is ...

Amy Schumer is having "a really good experience" with a new weight-loss drug, news that comes after she became ill using Wegovy and Ozempic in the recent past. The comedian told her Instagram ...

Fact checked by Nick Blackmer While GLP-1 drugs like Ozempic and Wegovy can lead to rapid and significant weight loss, they ...

She may be known for her comedy, butAmy Schumer showed a more vulnerable side as she became candid about her weight loss ...

Weight-loss drugs are trending, with Ozempic and the latest launch, Mounjaro—considered a likely equivalent to Ozempic—gaining popularity. But will these new drugs influence consumer buying patterns?

Weight loss “wonder drug” Wegovy will cost Irish users around €220 a month as it is not currently availably under either the ...

Zerodha CEO Nithin Kamath highlighted the transformative potential of weight-loss drugs Ozempic and Mounjaro, which help in ...

Carlsbad’s Ionis Pharmaceuticals struck a deal worth up to $940 million with Japan-based Ono Pharmaceutical for its medicine ...

It was only a matter of time until the GLP-1 receptor agonist drugs like Ozempic and Wegovy were superseded, and now it looks ...